TP53 and cancer: Since MDM4 is more highly expressed in cancer tissues than in normal tissues and dampens the tumor-suppressive functions of p53 (13, 14, 15, 16), alternative splicing of MDM4 mRNA is considered to be a critical step in cancer progression (17).